ToxSci Advance Access published online on April 11, 2006
Toxicological Sciences, doi:10.1093/toxsci/kfj192
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Pharmacology, Toxicology, and Therapeutics, University of Kansas Medical Center, Kansas City, KS 66160
* To whom correspondence should be addressed. Gender is an important factor in pharmacokinetics and pharmacodynamics. In the current study, gender difference in acetaminophen (APAP)-induced hepatotoxicity has been examined. Male and female mice were injected with a toxic dose of APAP (500 mg/kg, ip). Female mice were resistant to the hepatotoxic effects of APAP, depicted by serum alanine aminotransferase and sorbital dehydrogenase activities and histological analysis. Basal hepatic GSH levels were lower in females than in males, suggesting that basal GSH level may not be a factor in determining the gender difference of APAP hepatotoxicity. APAP metabolism was slower in females than males, revealed by lower levels of glucuronidation and sulfation and higher amounts of free APAP in the livers of female mice. Lower basal Cyp1a2 mRNA levels and lower expression of Cyp1a2 and Cyp3a11 mRNAs following APAP dosing were also observed in females compared with males. However, there was no gender difference in N-acetyl-p-benzoquinoneimine covalent binding 2 hours after APAP administration, suggesting similar APAP bioactivation between genders. Moreover, liver Gst pi mRNA levels were significantly lower in females than males. This finding is consistent with a previous report, which showed that Gst pi knockout mice are protected from APAP-induced liver toxicity. In conclusion, gender difference of APAP-induced hepatotoxicity is not likely due to APAP metabolism. Perhaps, it is in part due to gender-dependent Gst pi expression. However, the mechanism underlying the association between reduction in Gst pi expression and hepato-protective effect against APAP toxicity remains to be further explored.
Received December 15, 2005
Accepted April 5, 2006
Biotransformation and Toxicokinetics
Acetaminophen Metabolism Does Not Contribute to Gender Difference in Its Hepatotoxicity in Mouse
Guoli Dai 1,
Lin He 1,
Nathan Chou 1,
and
Yu-Jui Y. Wan 1 *
Yu-Jui Y. Wan, E-mail: ywan{at}kumc.edu
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
L. A. McConnachie, I. Mohar, F. N. Hudson, C. B. Ware, W. C. Ladiges, C. Fernandez, S. Chatterton-Kirchmeier, C. C. White, R. H. Pierce, and T. J. Kavanagh Glutamate Cysteine Ligase Modifier Subunit Deficiency and Gender as Determinants of Acetaminophen-Induced Hepatotoxicity in Mice Toxicol. Sci., October 1, 2007; 99(2): 628 - 636. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Fostel, L. Burgoon, C. Zwickl, P. Lord, J. C. Corton, P. R. Bushel, M. Cunningham, L. Fan, S. W. Edwards, S. Hester, et al. Toward a Checklist for Exchange and Interpretation of Data from a Toxicology Study Toxicol. Sci., September 1, 2007; 99(1): 26 - 34. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Botta, S. Shi, C. C. White, M. J. Dabrowski, C. L. Keener, S. L. Srinouanprachanh, F. M. Farin, C. B. Ware, W. C. Ladiges, R. H. Pierce, et al. Acetaminophen-induced Liver Injury Is Attenuated in Male Glutamate-cysteine Ligase Transgenic Mice J. Biol. Chem., September 29, 2006; 281(39): 28865 - 28875. [Abstract] [Full Text] [PDF] |
||||

